However, caution is needed for this mechanism to be a potential target for cancer immunotherapy because it has been shown that in vitro treatment of macrophages with the transferrin receptor ligand, transferrin, can promote the M2 polarization state; in other words, it can also contribute to cancer progression and therapeutic resistance [26]. This evidence concerns the gene TFRC and cancer.